Literature DB >> 6775949

Prolactin response to exercise, metoclopramide and other provacative agents in children.

K Ijaiya.   

Abstract

Metoclopramide (MCP), a derivative of procainamide was compared with exercise, arginine, insulin and thyrotropin releasing hormone (TRH) as a prolactin (PRL) releaser in children. The peak response of plasma PRL after oral administration of MCP was greater than that after strenuous exercise and after i.v. administration of pharmacodynamic agents. Normal PRL and TSH responses were observed after TRH administration in all subjects. Variable PRL responses were seen after exercise and after i.v. administration of arginine and insulin, despite significant growth hormone (GH) release following the administration of these agents. MCP produced no increase in plasma TSH. Metoclopramide may be useful for dynamic testing of PRL release in children. It can be taken orally and is free of side-effects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775949     DOI: 10.1007/bf00441478

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  51 in total

1.  Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.

Authors:  S Lal; C E De la Vega; T L Sourkes; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

2.  Letter: Metaclopramide and prolactin.

Authors:  A S McNeilly; M O Thorner; G Volans; G M Besser
Journal:  Br Med J       Date:  1974-06-29

3.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

4.  Hyperprolactinemia as a cause of delayed puberty: successful treatment with bromocriptine.

Authors:  M P Koenig; K Zuppinger; B Liechti
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

5.  Concordance of insulin-induced hypoglycemia and phenothiazine-induced prolactin secretion in man.

Authors:  M T Buckman; G T Peake
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

6.  Prolactin and growth hormone release in response to sequential stimulation by arginine and synthetic TRF.

Authors:  J S Rakoff; T M Siler; Y N Sinha; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

7.  Failure of insulin hypoglycemia to produce rise in serum prolactin.

Authors:  M P Cohen; R R Gala
Journal:  Am J Obstet Gynecol       Date:  1975-04-15       Impact factor: 8.661

8.  Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin.

Authors:  C R Edwards; I A Forsyth; G M Besser
Journal:  Br Med J       Date:  1971-08

9.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

10.  Impaired hypothalamic control of prolactin secretion in massive obesity.

Authors:  P G Kopelman; N White; T R Pilkington; S L Jeffcoate
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

View more
  2 in total

1.  Prolactin response to arginine in children with hyperthyroidism and primary hypothyroidism.

Authors:  K Abe; N Matsuura; H Fujita; K Fujieda; T Kato; Y Nohara; Y Mikami; N Fukushima
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

Review 2.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.